Inventor · disambiguated record
Philippe Muller
Also filed as: MULLER PHILIPPE
20 granted patents·2 pending applications·386 citations·filing 1996–2021
93Inventor score
Files withBONFANTI JEAN-FRANCOIS5JANSSEN R & D IRELAND3JANSSEN SCIENCES IRELAND UC3JANSSEN SCIENCES IRELAND UNLIMITED CO3TIBOTEC PHARM LTD3
Top patents by PatentIndex Score
22 records- 0198US6420387B1Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivativesJANSSEN PHARMACEUTICA NV·Filed 2000·Granted Jul 16, 2002·97 cites·2 claims
- 0297US6037350AFarnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivativesJANSSEN PHARMACEUTICA NV·Filed 1996·Granted Mar 14, 2000·112 cites·27 claims
- 0395US9556176B2Purine derivatives for the treatment of viral infectionsJANSSEN R&D IRELAND·Filed 2012·Granted Jan 31, 2017·29 cites·4 claims
- 0495US6169096B1Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivativesJANSSEN PHARMACAEUTIC N V·Filed 1999·Granted Jan 2, 2001·133 cites·14 claims
- 0582US10266543B2Macrocyclic deaza-purinones for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UC·Filed 2014·Granted Apr 23, 2019·2 cites·20 claims
- 0676US10280167B2Purine derivatives for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UC·Filed 2017·Granted May 7, 2019·1 cites·4 claims
- 0776US8034835B21-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogsTIBOTEC PHARM LTD·Filed 2006·Granted Oct 11, 2011·3 cites·13 claims
- 0873US9725432B2Pyrimidine derivatives for the treatment of bacterial diseasesJANSSEN R&D IRELAND·Filed 2013·Granted Aug 8, 2017·2 cites·4 claims
- 0973US2022235052A1Purine derivatives for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 1072US7449463B2Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replicationTIBOTEC PHARM LTD·Filed 2004·Granted Nov 11, 2008·6 cites·36 claims
- 1170US11702426B2Macrocyclic deaza-purinones for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Granted Jul 18, 2023·0 cites·11 claims
- 1270US10280180B2Macrocyclic purines for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UC·Filed 2013·Granted May 7, 2019·1 cites·8 claims
- 1368US10829494B2Macrocyclic deaza-purinones for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Nov 10, 2020·0 cites·17 claims
- 1454US8278455B25- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2008·Granted Oct 2, 2012·0 cites·12 claims
- 1553US8883837B2Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2008·Granted Nov 11, 2014·0 cites·28 claims
- 1651US7928097B2Photoreactive compounds and compositionsSADLER PETER J·Filed 2007·Granted Apr 19, 2011·0 cites·16 claims
- 1749US2007093502A15- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2004·Application pending·0 cites
- 1848US10221157B2Pyrimidine derivatives for the treatment of bacterial diseasesJANSSEN R&D IRELAND·Filed 2017·Granted Mar 5, 2019·0 cites·2 claims
- 1948US7176327B2Photoreactive compounds and compositionsUNIV EDINBURGH·Filed 2002·Granted Feb 13, 2007·0 cites·17 claims
- 2043US8044073B2Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replicationTIBOTEC PHARM LTD·Filed 2004·Granted Oct 25, 2011·0 cites·29 claims
- 2142US8178694B2Heterocyclylaminoalkyl substituted benzimidazolesBONFANTI JEAN-FRANCOIS·Filed 2006·Granted May 15, 2012·0 cites·15 claims
- 2242US7884215B22-substituted benzimidazolesBONFANTI JEAN-FRANCOIS·Filed 2006·Granted Feb 8, 2011·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Philippe Muller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →